The medical record retrieval software provider, which received funding from Merck & Co in 2013, has secured $41m from Aldrich Capital Partners.

Scotiabank has supplied University of Calgary-affiliated Well Doc Alberta with funding under a pact signed when it bought MD Financial Management last year.

The physician-based social media platform has raised $11m in a round co-led by Itochu, which supplied $6m, and existing backer Singapore Press Holdings.

Scythian Biosciences-backed cannabis facilities operator Verano has agreed to an $850m acquisition by Harvest Health and Recreation in an all-stock transaction.

Lilly Asia Ventures has returned for a series C round that boosted the total raised by the cancer and metabolic disease drug developer to $100m.

Harvard has partnered Deerfield to launch commercialisation firm Lab1636 with $100m in funding in order to advance life science projects towards the clinic and establish spinouts.

OUP has closed an oversubscribed third fund that it expects will invest in 40 to 50 spinouts, primarily originating from 19 core partner institutions.

The accelerator will support up to 12 health projects at a time, led by innovators including UW Health faculty and with resources provided by four partners including Warf.

Garwood Medical Devices is developing two therapeutic electrode-powered products based on licences from University of Buffalo, having last raised $3.6m in 2016.

Founding investor Lundbeckfonden Emerge returned to co-lead a series A round for the gene editing drug developer with Life Science Partners.